Published in Clin Psychopharmacol Neurosci on May 31, 2017
Comparing the Effects of Bupropion and Escitalopram on Excessive Internet Game Play in Patients with Major Depressive Disorder. Clin Psychopharmacol Neurosci (2017) 0.75
Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry (2000) 9.02
New insights into BDNF function in depression and anxiety. Nat Neurosci (2007) 3.94
The epidemiology of major depressive episodes: results from the International Consortium of Psychiatric Epidemiology (ICPE) Surveys. Int J Methods Psychiatr Res (2003) 3.36
Cytokines and psychopathology: lessons from interferon-alpha. Biol Psychiatry (2004) 2.83
Neurobiology of resilience. Nat Neurosci (2012) 2.13
5-HT(1A) receptor function in major depressive disorder. Prog Neurobiol (2009) 1.99
Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS). Front Neuroendocrinol (2008) 1.87
Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative-antioxidative systems. Hum Psychopharmacol (2007) 1.77
Metabolic syndrome predisposes to depressive symptoms: a population-based 7-year follow-up study. J Clin Psychiatry (2008) 1.65
Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. Neurosci Biobehav Rev (2011) 1.58
DHEA and its transformation into androgens and estrogens in peripheral target tissues: intracrinology. Front Neuroendocrinol (2001) 1.57
Dehydroepiandrosterone treatment of midlife dysthymia. Biol Psychiatry (1999) 1.57
Understanding the heterogeneity of depression through the triad of symptoms, course and risk factors: a longitudinal, population-based study. J Affect Disord (2000) 1.54
Neuroactive steroid regulation of neurotransmitter release in the CNS: action, mechanism and possible significance. Prog Neurobiol (2009) 1.51
Pathophysiology of depression: do we have any solid evidence of interest to clinicians? World Psychiatry (2010) 1.50
Functional biomarkers of depression: diagnosis, treatment, and pathophysiology. Neuropsychopharmacology (2011) 1.44
Adrenal steroid secretion and major depression in 8- to 16-year-olds, III. Influence of cortisol/DHEA ratio at presentation on subsequent rates of disappointing life events and persistent major depression. Psychol Med (1998) 1.41
Increase in interleukin-1beta in late-life depression. Am J Psychiatry (2005) 1.40
Monoamine dysfunction and the pathophysiology and treatment of depression. J Clin Psychiatry (1998) 1.39
Endogenous levels of dehydroepiandrosterone sulfate, but not other sex hormones, are associated with depressed mood in older women: the Rancho Bernardo Study. J Am Geriatr Soc (1999) 1.37
Homocysteine and folate metabolism in depression. Prog Neuropsychopharmacol Biol Psychiatry (2005) 1.25
Relationships of dehydroepiandrosterone sulfate in the elderly with functional, psychological, and mental status, and short-term mortality: a French community-based study. Proc Natl Acad Sci U S A (1996) 1.21
Steroids, neuroactive steroids and neurosteroids in psychopathology. Prog Neuropsychopharmacol Biol Psychiatry (2004) 1.17
Dehydroepiandrosterone (DHEA)--a precursor steroid or an active hormone in human physiology. J Sex Med (2011) 1.16
Pathophysiology of HPA axis abnormalities in patients with major depression: an update. Am J Psychiatry (1989) 1.06
Effects of a two-week physiological dehydroepiandrosterone substitution on cognitive performance and well-being in healthy elderly women and men. J Clin Endocrinol Metab (1997) 1.05
Dehydroepiandrosterone (DHEA) treatment of depression. Biol Psychiatry (1997) 1.00
DHEA and DHEA-S response to acute psychosocial stress in healthy men and women. Biol Psychol (2012) 0.99
Differential association of somatic and cognitive symptoms of depression and anxiety with inflammation: findings from the Netherlands Study of Depression and Anxiety (NESDA). Psychoneuroendocrinology (2013) 0.99
Salivary dehydroepiandrosterone secretion in response to acute psychosocial stress and its correlations with biological and psychological changes. Biol Psychol (2008) 0.97
Placebo-controlled trial of dehydroepiandrosterone (DHEA) for treatment of nonmajor depression in patients with HIV/AIDS. Am J Psychiatry (2006) 0.94
Dehydroepiandrosterone sulfate (DHEAS) counteracts decremental effects of corticosterone on dentate gyrus LTP. Implications for depression. Brain Res Bull (2000) 0.89
Relationships among plasma dehydroepiandrosterone and dehydroepiandrosterone sulfate, cortisol, symptoms of dissociation, and objective performance in humans exposed to underwater navigation stress. Biol Psychiatry (2009) 0.89
DHEA lessens depressive-like behavior via GABA-ergic modulation of the mesolimbic system. Neuropsychopharmacology (2008) 0.88
Novel biomarkers in major depression. Curr Opin Psychiatry (2013) 0.87
Increased diurnal plasma concentrations of dehydroepiandrosterone in depressed patients. J Clin Endocrinol Metab (1998) 0.87
Serum dehydroepiandrosterone (DHEA) and DHEA-sulfate (S) levels in medicated patients with major depressive disorder compared with controls. J Affect Disord (2012) 0.87
Depression and sex hormones in elderly women. Arch Gerontol Geriatr (2004) 0.86
The effects of dehydroepiandrosterone (DHEA) in the treatment of depression and depressive symptoms in other psychiatric and medical illnesses: a systematic review. Curr Drug Targets (2014) 0.84
Supplementation with DHEA: effect on muscle size, strength, quality of life, and lipids. J Womens Health (Larchmt) (2005) 0.81
Clinical significance of decreased protein expression of dehydroepiandrosterone sulfate in the development of depression: a meta-analysis. J Affect Disord (2014) 0.79
Homogeneity of Beck's Depression Inventory (BDI): applying Rasch analysis in conceptual exploration. Acta Psychiatr Scand (1987) 0.76